|
|
Post by Hot Christian Stocks on Feb 28, 2014 9:32:07 GMT -5
$PLPL Plandaí subsidiary, Cannabis Biosciences, Inc., will be developing and testing a botanical extract derived from cannabis, and the company its marijuana research will address neural disorders with. Specifically, the company believes that the phytonutrients in cannabis show excellent potential for treating and preventing a host of neuron and injury related brain diseases including Parkinson's, Alzheimer's, ALS, MS, epilepsy, PTSD and post-concussion syndrome www.stockwatch.com/News/Item.aspx?bid=U-by410935-U%3aPLPL-20140114&symbol=PLPL®ion=U |
|
|
|
Post by Hot Christian Stocks on Mar 3, 2014 9:33:13 GMT -5
$PLPL - Plandai Biotechnology: A Natural Fit Into the Marijuana Industry NEW YORK, NY -- (Marketwired) -- 03/03/14 Plandaí Biotechnology (OTCQB: PLPL) has a strong executive team in place, a well thought out business plan, and now it's time for the company to make its products the star. These products include Plandaí's Phytofare botanical extracts such as its Green Tea Catechin Complex and the Limonoid Glycoside Complex, as well as a line of Diego Pellicer® medical cannabis products. It is the latter could make the company a leader in the marijuana industry. Plandaí entered the marijuana space in November 2013, and since that time, the biotech has moved quickly to develop its Phytofare cannabis extracts, it has also found a branding partner in Diego Pellicer, Inc., and it named former Microsoft executive Jamen Shively as the company's Vice President of Global Marketing to build and market the brand of cannabis extracts. None of this should be a surprise however, as Plandaí very well could be the most natural fit of any publicly traded company into the marijuana arena. After all, Plandaí is a producer of highly bioavailable plant extracts for the health, wellness, nutraceutical, and pharmaceutical industries, so adding an additional plant (cannabis) for development into the lineup of botanicals the company already works with (green tea, limonoids) only enhances its product offerings. But, it doesn't stop there. What sets Plandaí apart from many other companies working with botanicals is its hydrodynamic extraction process that allows the company to use science to achieve the most bioavailability from those plants. While tetrahydrocannabinol (THC) has demonstrated the ability to reduce tumors and slow the progression of Alzheimer's, it is the second largest constituent of cannabis, cannabidiol (CBD), which doesn't have psychoactive properties that will likely be the primary focus of Plandaí's testing. A number of recent studies that show the healing and treatment benefits of cannabinoids in diseases like diabetes, ALS, Crohn's disease, multiple sclerosis, among others favor a biotech company like Plandaí that will engage in its own studies using cannabis. www.stockwatch.com/News/Item.aspx?bid=U-i1094447-U%3aPLPL-20140303&symbol=PLPL®ion=U |
|
|
|
Post by Hot Christian Stocks on Mar 4, 2014 9:25:13 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Mar 5, 2014 9:25:01 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Mar 6, 2014 9:17:20 GMT -5
$PLPL Legalizing Medical Marijuana Gaining More Momentum in Mid-Term Election YearNEW YORK, NY -- (Marketwired) -- 03/06/14 Plandaí Biotechnology (OTCQB: PLPL) is one of a handful of publicly traded companies that are eagerly anticipating the legalization of medical marijuana nationwide. Currently the drug is legal medicinally in 20 states and Washington, D.C., but in this election year, that number is likely to grow. In each national election year, the frenzy begins again and with it, a growing momentum that has the U.S. drawing closer to a nationwide acceptance. Read More www.stockwatch.com/News/Item.aspx?bid=U-i1095827-U%3aPLPL-20140306&symbol=PLPL®ion=U
|
|
|
|
Post by Hot Christian Stocks on Mar 7, 2014 9:32:27 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Mar 7, 2014 12:27:32 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Mar 10, 2014 8:43:08 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Mar 11, 2014 6:08:13 GMT -5
$PLPL pre-mkt News! Plandai Assumes Role in Legalizing Medical Marijuana in South Africa SEATTLE, WA(eTeligis.com)Planda Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that it will assume a role in helping to craft legislation that is expected to result in the eventual legalization of marijuana for medical purposes in South Africa. Planda has retained the law firm Werksmans Attorneys, (LEX Africa) Sandton, South Africa, which includes health law as one of its specialties, to draft and file the company's comments on a recently introduced legislative bill that if passed, would effectively legalize medical marijuana in that country and pave the way for expanded research. The Medical Innovation Bill was introduced in the legislature in February by terminally-ill IFP MP Mario Oriani-Ambrosini who stated in his introduction that, "...millions of people were going through the hell of being a cancer patient, and die and suffer, possibly unnecessarily, because government was not funding research and expediting approval for treatments where there was no profit to be made." Oriani-Ambrosini said tabling the bill to get the law changed was something he had to do. "This is my contribution to something that had to be done. I did not look for this fight... It found me." Under current South African legislation, medical practitioners are legally denied the right to prescribe certain proven effective and harmless medication to their patients, which includes cannabis, on the basis that there are insufficient legally required double blind clinical studies. However, such studies are often considered economically unviable as cannabis, a plant that is in the public domain, cannot be patented by big pharmaceutical companies. The bill's objectives are to establish one or more research hospitals where medical innovation can take place, especially with regard to the treatment and cure of cancer. The bill would also legalize the medical, industrial and commercial use of cannabis in South Africa in accordance with emerging world standards. Oriani-Ambrosini also pointed out the potential economic benefits of legalized cannabis in South Africa, including tax revenue and jobs in agriculture and industrial production. Commenting on the bill, Planda Vice President, Jamen Shively, stated, "As one of the few companies out there with a vested interest in medicinal cannabis research, and the stated goal of furthering such research, we see ourselves as duty-bound to help craft legislation and to support those institutions that are paving the way in this emerging field. The medical cannabis industry has been surviving solely on anecdotal evidence and limited medical research for too long. It is time to invest in legitimate, double blind human studies to confirm the effectiveness of cannabis therapy for not only cancers but also neural diseases such as Parkinson's, Alzheimer's, MS, PTSD and epilepsy. We applaud Mr. Oriani-Ambrosini for his pioneering legislation and look forward to doing our part in not only supporting his efforts but also funding research in South Africa if the bill eventually passes." www.stockwatch.com/News/Item.aspx?bid=U-et410210341-U%3aPLPL-20140311&symbol=PLPL®ion=U
|
|
|
|
Post by Hot Christian Stocks on Mar 12, 2014 8:35:25 GMT -5
$PLPL -states - Medical Innovation Bill was introduced in the legislature in Feb by terminally-ill IFP MP Mario Oriani-Ambrosini who stated in his introduction that, "...millions of people were going through the hell of being a cancer patient, and die and suffer, possibly unnecessarily, because government was not funding research and expediting approval for treatments where there was no profit to be made." www.stockwatch.com/News/Item.aspx?bid=U-et410210341-U%3aPLPL-20140311&symbol=PLPL®ion=U |
|
|
|
Post by Hot Christian Stocks on Mar 13, 2014 7:11:18 GMT -5
|
|
|
|
Post by Hot Christian Stocks on Mar 14, 2014 8:43:12 GMT -5
Commenting on the mj bill, $PLPL Plandai Vice President, Jamen Shively, stated, "As one of the few companies out there with a vested interest in medicinal cannabis research, and the stated goal of furthering such research, we see ourselves as duty-bound to help craft legislation and to support those institutions that are paving the way in this emerging field. The medical cannabis industry has been surviving solely on anecdotal evidence and limited medical research for too long. It is time to invest in legitimate, double blind human studies to confirm the effectiveness of cannabis therapy for not only cancers but also neural diseases such as Parkinson's, Alzheimer's, MS, PTSD and epilepsy. We applaud Mr. Oriani-Ambrosini for his pioneering legislation and look forward to doing our part in not only supporting his efforts but also funding research in South Africa if the bill eventually passes." www.stockwatch.com/News/Item.aspx?bid=U-et410210341-U%3aPLPL-20140311&symbol=PLPL®ion=U |
|
|
|
Post by Hot Christian Stocks on Mar 17, 2014 6:15:45 GMT -5
$PLPL - Plandai Vice President, Jamen Shively, stated, "As one of the few companies out there with a vested interest in medicinal cannabis research, and the stated goal of furthering such research, we see ourselves as duty-bound to help craft legislation and to support those institutions that are paving the way in this emerging field. The medical cannabis industry has been surviving solely on anecdotal evidence and limited medical research for too long. It is time to invest in legitimate, double blind human studies to confirm the effectiveness of cannabis therapy for not only cancers but also neural diseases such as Parkinson's, Alzheimer's, MS, PTSD and epilepsy. We applaud Mr. Oriani-Ambrosini for his pioneering legislation and look forward to doing our part in not only supporting his efforts but also funding research in South Africa if the bill eventually passes." www.stockwatch.com/News/Item.aspx?bid=U-et410210341-U%3aPLPL-20140311&symbol=PLPL®ion=U |
|
|
|
Post by Hot Christian Stocks on Mar 18, 2014 7:09:13 GMT -5
$PLPL is one of the few cannabis OTC companies that is eagerly anticipating the legalization of medical marijuana nationwide. Currently the drug is legal medicinally in 20 states and Washington, D.C., but in this election year, that number is likely to grow. In each national election year, the frenzy begins again and with it, a growing momentum that has the U.S. drawing closer to a nationwide acceptance www.stockwatch.com/News/Item.aspx?bid=U-i1095827-U%3aPLPL-20140306&symbol=PLPL®ion=U |
|
|
|
Post by Hot Christian Stocks on Mar 18, 2014 10:48:37 GMT -5
|
|
